|
Follow the links below to find systematic reviews of the evidence for the effectiveness of hormone replacement therapies.
Created Sept 2007
Printer friendly page
| Results 1 to 11 displayed. |
| Title: |
Hormone replacement therapy for cognitive function in postmenopausal women
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Animal studies (performed both in the laboratory and on living animals) suggest that estrogen alone might protect the brain as women get older. After the menopause, levels of estrogens decline in women and estrogen therapy has been claimed to maintain o...
|
| Date: |
Sep 2007
|
| Title: |
Exercise for vasomotor menopausal symptoms
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Evidence suggests that a high proportion of menopausal women will experience hot flushes and night sweats (vasomotor symptoms). Hormone replacement therapy (HRT) is considered to be the most effective treatment for symptoms. However, studies have report...
|
| Date: |
Aug 2007
|
| Title: |
Thyroid hormone replacement for subclinical hypothyroidism
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Subclinical hypothyroidism is a condition where some laboratory findings point at a thyroid gland not working properly. Patients with subclinical hypothyroidism may have vague, non-specific symptoms of actual hypothyroidism (for example dry skin, cold s...
|
| Date: |
May 2007
|
| Title: |
Testosterone for peri- and postmenopausal women
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
The value of adding adjuvant testosterone to hormone therapy for peri-and postmenopausal women's health is controversial. This systematic review examines the benefits and the risks of such therapy. The small number of studies appropriate for inclusion i...
|
| Date: |
Aug 2005
|
| Title: |
Long term hormone therapy for perimenopausal and postmenopausal women
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Hormone therapy (HT) is widely used for controlling menopausal symptoms. It has also been used for the management and prevention of chronic diseases such as cardiovascular disease, osteoporosis and dementia in older women. The present review set out to ...
|
| Date: |
May 2005
|
| Title: |
Hormone replacement therapy for preventing cardiovascular disease in post-menopausal women
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
The authors analysed the data from the 10 clinical trials - two involved healthy women and eight involved women with heart disease. Altogether the trials included about 24,000 women who had been randomly assigned to take either hormones or placebos (dum...
|
| Date: |
Feb 2005
|
| Title: |
Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Hot flushes and night sweats are common symptoms around the menopause (the end of menstrual periods in a woman's life). During menopause there is a major reduction in sex hormones produced by the ovaries that cause these symptoms. The review of scientif...
|
| Date: |
Aug 2004
|
| Title: |
Gonadotrophin-releasing hormone analogues for endometriosis: bone mineral density
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
Both hormone replacement therapy and danazol stop the loss of bone density that occurs when women take gonadotrophin-releasing hormone analogues for endometrosis Endometriosis is a painful condition caused where tissue from the lining of the uterus ...
|
| Date: |
Aug 2003
|
| Title: |
Hormone replacement therapy to maintain cognitive function in women with dementia
|
| Publisher: |
John Wiley and Sons, Ltd. for The Cochrane Collaboration
|
| Description: |
There is no evidence that estrogen replacement therapy can maintain cognitive function for up to a year in women with Alzheimer's disease (AD). Estrogens have been shown to have potentially beneficial effects on the brain. After the menopause in wom...
|
| Date: |
May 2002
|
| Results 1 to 11 displayed. |
|